Live Breaking News & Updates on Interchangeability

Stay updated with breaking news from Interchangeability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Defining Interchangeability and Switching in Biologics

Medical experts discuss interchangeability designation requirements for biosimilars. ....

Ryan Haumschild , Bincy Abraham , Aliceb Gottlieb , Vibeke Strand , Reference Product , Cpt 13 ,

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1

In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more. ....

Ryan Haumschild , Pharmacy Services At Emory Healthcare , Winship Cancer Institute , Pharmacy Services , Emory Healthcare , Winship Cancer ,

FDA Accepts sBLA for Interchangeability Designation for Adalimumab-bwwd

HADLIMA is currently indicated for psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa, among others. ....

United States , Jon Martin , Samsung Bioepis Co Ltd , Organon Co , Regulatory Affairs Team Leader At Samsung Bioepis , Supplemental Biologics License Application , Araki Illustrations , Byoung In Jung , Vice President , Regulatory Affairs Team Leader , Samsung Bioepis ,

Decision-Making Process Surrounding Biosimilar Implementation

Experts compare approaches to prescribing biosimilars over reference drugs. ....

Aliceb Gottlieb , Bincy Abraham , Ryan Haumschild , Jamiet Brogan , Vibeke Strand , Evidence Based Medicine , Psoriatic Arthritis , Prior Authorization ,

Interchangeability of Biosimilars in Ophthalmology

Michael A. Klufas, MD, discusses the significance of interchangeability of biosimilars and being able to substitute biosimilars for reference products, as well as the path to achieving the designation of interchangeability from the FDA. ....

Michaela Klufas , Wet Amd , Age Related Macular Edema ,